Recombinant hirudin in the prevention of venous thromboembolism in patients undergoing elective hip surgery

Seminars in Thrombosis and Hemostasis

Volumn 23, Issue 2, 1997, Pages 143-148

  Agnelli, Giancarlo ^a   Sonaglia, Francesco ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Deep vein thrombosis; Orthopedic surgery; Recombinant hirudin; Venous thromboembolism

Indexed keywords

HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN;

CLINICAL TRIAL; DEEP VEIN THROMBOSIS; HIP SURGERY; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030952162     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996082     Document Type: Short Survey

References (29)

1. Prandoni P, AWA Lensing, A Cogo, S Cuppini, S Villalta, M Carta, AM Cattelan, P Polistena, E Bernardi, MH Prins: The longterm clinical outcome of acute deep vein thrombosis. Ann Intern Med 125:1-7, 1996.
2. Agnelli G, S Radicchia, GG Nenci: Diagnosis of deep vein thrombosis in asymptomatic high-risk patients. Haemostasis 25:40-48, 1995.
3. Collins R, A Scrimgeour, S Yusuf, et al: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 318:1162-1170, 1988.
4. Nurmohamed MT, FR Rosendaal, HR Büller, E Dekker, DW Hommes, JP Vandenbroucke, E Briet: Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis. Lancet 340:152-156, 1992.
5. Leizorovicz A, MC Haugh, FR Chapuis, MM Samama, JP Boissel: Low molecular weight heparin in the prevention of perioperative thrombus. Br J Med 305:913-920, 1992.
6. Mohr DN, MD Silverstein, PA Murtaugh, JM Harrison: Prophylactic agent for venous thrombosis in elective hip surgery. Arch Intern Med 153:2221-2228, 1993.
7. Imperiale TF, T Speroff: A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 271:1780-1786, 1994.
8. Leclerc JR, WH Geerts, L Desjardin, GH Laflamme, B L'Esperance, C Demers, J Kassis, M Cruickshank, L Whitman, F Delorme: Prevention of venous thromboembolism following knee arthroplasty. A randomized, double blind trial comparing enoxaparin with warfarin. Ann Intern Med 124:619-626, 1996.
9. Clagett GP, FA Anderson, J Heith, MN Levine, HB Wheeler: Prevention of venous thromboembolism. Chest 108:312S-333S, 1995.
10. Agnelli G, C Pascucci. B Cosmi, GG Nenci: The comparative effects of recombinant hirudin (CGP39393) and standard heparin in thrombus growths in rabbits. Thromb Haemostas 63:204-207, 1990.
11. Bucha E, G Nowak, F Markwardt: Prevention of experimental coronary thrombosis by hirudin. Folia Haematol (Leipzig) 115: 52-58, 1988.
12. Bichler J, B Fichtl, M Siebeck, H Fritz: Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration. Drug Res 38:704-710, 1988.
13. Schiele F, A Vuillemenot, P Kramarz, V Kieffer, J Soria, C Soria, A Camez, MC Mirshahi, JP Bassand: A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis. Thromb Haemostas 71:558-562, 1994.
14. Schiele F, A Vuillemenot, P Kramarz, V Kieffer, T Anguenot, Y Bernard, JP Bassand: Use of recombinant hirudin as antithrombotic treatment in patients with heparin-indueed thrombocytopenia. Am J Hematol 50:20-25, 1995.
15. Maraganiore JM, B Chao, ML Joseph, el al: Anticoagulant activity of synthetic hirudin fragments. J Biol Chem 264:8692-8698, 1989.
16. Kline T, C Hammond, P Bourdon, JM Maraganore: Hirulog peptides with scissile bond replacements resistant to thrombin cleavage. Biochem Biophys Res Commun 177:1049-1055, 1991.
17. Kettner C, E Shaw: D-Phe-Pro-Arg CH, Cl: A selective affinity label for thrombin. Thromb Res 14:969-973, 1979.
18. Knabb RM, CA Kettner, PB Timmerans, TM Reilly: In vivo characterization of a new synthetic thrombin inhibitor. Thromb Haemostas 67:56-59, 1992.
19. Bock LC, LC Griffin, JA Latham, EH Vermaas, JJ Toole: Selection of single-stranded DNA molecule that bind and inhibit human thrombin. Nature 355:564-566, 1992.
20. Harvey RP, E Degryse, L Stefani, F Schamber, JP Cazenave, M Courtney, P Tolstoshev, JP Lecocq: Cloning and expression of a cDN A coding for the anticoagulant hirudin from bloodsucking leech. Hirudo medicinalis. Proc Natl Acad Sci USA 83:1084-1088, 1986.
21. Stone SR, J Hofsteenge: Kinetics of inhibition of thrombin by hirudin. Biochemistry 177:1049-1055, 1990.
22. Rydel TJ, KG Ravichandran, A Tulinsky, W Bode, R HuBer, C Roitsch, JW Fenton: The structure of a complex of recombinant hirudin and α-human thrombin. Science 29:7095-7101, 1990.
23. Märki WE, RB Wallis: The anticoagulant and antithrombotic properlies of hirudins. Thromb Huemostas 64:344-348, 1990.
24. Eriksson BI, P Kalebo, S Ekman, S Lindbratt, R Kerry. P Close: Direct thrombin inhibition with rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement. Thromb Haemostas 72:227-231, 1994.
25. Eriksson BI, S Ekman, P Kalebo, B Zachrisson, D Bach, P Close: Prevention of deep vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin. CGP 39393. Lancet 347:635-639, 1996.
26. Levine MN, J Hirsh: Clinical potential of low molecular weight heparins. Baillieres Clin Haematol 3:545-554, 1990.
27. Ekman S, BI Eriksson, S Lindbratt, C Toerholm, P Kälebo, M Baur, D Bach, P Close: Recombinant hirudin CGP39393 (™ Revasc Ciha). is the most effective and safe prophylaxis of thromboembolic complications in patients undergoing total hip replacement. Thromb Haemostas 73:1093 (Abstr), 1995.
28. Eriksson BI, P Mouret, P Käleho, M Baur, S Ekman, S Lindhratt, D Bach, P Close: Recombinant hirudin CGP 39393 (™ REVASC), is more effective than enoxaparin as prophylaxis of thromboembolic complications in patient undergoing total hip replacement. Haemostasis 26:624 (AbMr), 1996.
29. Geerts WH, RM Jay, KI Code, E Chen, JP Saibil, PA Hamilton: A comparison of low-dose heparin with low molecular weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:701-707, 1996.